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Tuberous Sclerosis Complex (TSC) is a multisystem
genetic disorder characterized by hamartomatous
neurological lesions that exhibit abnormal cell
proliferation and differentiation. Hyperactivation of
mTOR pathway by mutations in either the Tsc1 or
Tsc2 gene underlies TSC pathogenesis, but involve-
ment of specific neural cell populations in the
formation of TSC-associated neurological lesions
remains unclear. We deleted Tsc1 in Emx1-express-
ing embryonic telencephalic neural stem cells (NSCs)
and found that mutant mice faithfully recapitulated
TSC neuropathological lesions, such as cortical
lamination defects and subependymal nodules
(SENs). These alterations were caused by enhanced
generation of SVZ neural progeny, followed by their
premature differentiation and impaired maturation
during both embryonic and postnatal development.
Notably, mTORC1-dependent Akt inhibition and
STAT3 activation were involved in the reduced self-
renewal and earlier neuronal and astroglial differenti-
ation of mutant NSCs. Thus, finely tuned mTOR acti-
vation in embryonic NSCs may be critical to prevent
development of TSC-associated brain lesions.
INTRODUCTION
Aberrantly elevated mTOR pathway activity due to mutations in
the Tsc1 or Tsc2 gene underlies the pathogenesis of Tuberous
Sclerosis Complex (TSC), a multisystem, autosomal-dominant
disorder highly prevalent in children. TSC is characterized by
benign, focal malformations called hamartomas, which com-Celprise nonmalignant cells exhibiting abnormal cell proliferation
and differentiation. Notably, hamartomas are also observed in
the central nervous system (CNS), where they are responsible
for disabling neurological clinical features, such as epilepsy,
severe mental retardation, and autism, which, together with the
formation of brain tumors, account for significant morbidity and
mortality (Crino et al., 2006).
The neurological and neuropsychiatric manifestations of TSC
are related to specific developmental abnormalities, the cortical
tubers (CTs), characterized by disorganized lamination and by
the presence of aberrant cells, such as dysplastic neurons, large
astrocytes, and giant cells. Tubers form during embryogenesis
and serve as epileptogenic foci (Holmes and Stafstrom, 2007).
Other brain malformations are the subependymal nodules
(SENs), i.e., asymptomatic glio-neuronal benign lesions, located
in the lateral and third ventricles (Ridler et al., 2004), which
develop during fetal life and often degenerate into tumors,
named subependymal giant cell astrocytomas (SEGAs).
Interestingly, dysplastic neurons and giant cells express
cellular markers normally detected in the stem/progenitor cells
located within the embryonic ventricular zone (VZ) and the adult
subventricular zone (SVZ), suggesting that these lesions may
arise pathogenically from neural stem cells (NSCs) undergoing
abnormal differentiation (Ess et al., 2004; Orlova et al., 2010).
According to this hypothesis, CTs might be described as
‘‘ectopic’’ neurogenic compartments in which the mechanisms
finely tuning the acquisition of functional competence are
deregulated during embryonic development. Likewise, SENs
and SEGAs might originate from the uncontrolled proliferation
of SVZ NSCs, which proliferate abnormally during embryogen-
esis and acquire malignant characteristics postnatally. To date,
this hypothesis has not been formally proven. Given that hyper-
activation of the mTOR pathway deregulates self-renewal and
multilineage differentiation of different stem cell (SC) types,
such as germinal (Hobbs et al., 2010; Sun et al., 2010), epidermal
(Castilho et al., 2009), and hematopoietic SCs (Gan et al., 2008),l Stem Cell 9, 447–462, November 4, 2011 ª2011 Elsevier Inc. 447
Figure 1. Targeted Inactivation of Tsc1 in the eNSCs Results in Postnatal Megalencephaly and Cortical and Hippocampal Alterations
(A) Increased cortical thickness and pS6 staining in NeuN-immunoreactive (-IR) neuronal cells of P15 Tsc1c//Emx1-Cre+ mice. GFAP-IR cells do not express
pS6. Ectopic pS6/NeuN-IR cell layer in mutant cortex is indicated by an arrow. cc, corpus callosum. Magnification 1003, insets 6003.
(B) Western blot of control and mutant cortex at P15. (*), aspecific band. Tsc1 and Tsc2 expression was normalized over b-tubulin. pAktS473, pERK, and
pS6S235/236 activation over the corresponding total protein (five animals per genotype) is shown.
(C) Western blot of control and mutant cortex at P15. Raptor and Rictor expression was normalized over b-tubulin, while pmTORS2481 and pmTORS2448 is shown
over the corresponding total protein (five animals per genotype).
(D) IHC on P15 control andmutant cortex for pS6, NeuN, GFAP, and Smi311 (magnification 2003, inset 6003). Microglia activation in Tsc1mutant brains is shown
by Iba-1 staining.
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mTOR Tunes NSC Self-Renewal, Differentiationwe set out to understand the role of mTOR in the regulation of the
NSC compartment.
Recently, by targeting Tsc1 loss in differentiating/differenti-
ated neuronal cells (Meikle et al., 2007; Ehninger et al., 2008)
and astrocytes (Uhlmann et al., 2002a), several mouse models
for TSC have been generated, which, although displaying
epilepsy and some cortical alterations, did not fully recapitulate
the disease. Only recently, by deleting Tsc2 in radial glial cells
at E13.5, have some TSC neurological alterations been modeled
(Way et al., 2009). To improve the specificity and the pathological
significance of cell targeting, we generated a conditional mouse
in which Tsc1 expression was deleted at E9.5 in the Emx1-ex-
pressing embryonic dorsal telencephalic neuroepithelium, which
gives rise to the cerebral cortex and contributes to the postnatal
SVZ, i.e., the two brain regions in which CTs and SEN/SEGAs
arise in patients (Gorski et al., 2002; Young et al., 2007). This
conditional mouse model recapitulated several distinctive
neurological features of TSC, such as alterations in cortical lami-
nation, induction of spontaneous epileptic seizures, and devel-
opment of aberrantly expanded SVZ regions, closely resembling
SENs. Therefore, our mouse model might be considered a valu-
able preclinical model of TSC.
RESULTS
Hyperactivation of the mTOR Pathway in the Dorsal
Telencephalic Neuroepithelium Interferes with Proper
CNS Development
To explore the effect of Tsc1 loss in embryonic NSCs (eNSCs),
we crossed Tsc1 floxed mice with Emx1-Cre mice, obtaining
Tsc1c/c/Emx1-Cre+ and Tsc1c//Emx1-Cre+ mutant mice, which
were born in Mendelian ratios and were indistinguishable from
control mice until postnatal day (P)4. Starting at this time
point, mutants failed to gain weight (Figures S1A–S1C, available
online), and at P15 they displayed reduction in body organ size
(Figure S1D) with the exception of the brain, which was enlarged
and displayed reduced olfactory bulbs (OBs) and macroscopic
signs of hydrocephalus (Figures S1E and S1F). By P13, mutants
showed a progressive decline in activity and developed a
humped posture, eventually dying with a median survival time
of 18 days (Figure S1G).
A substantial conversion of the Tsc1 conditional allele into the
null allele (Figure S1H) and Cre recombination in cortical embry-
onic cells were demonstrated by detection of GLAST/GFP-(E) High pS6 activation was detected in the sPy in CA1/CA3 regions and in the hilu
the mutant slm (magnification 403, insets 2003). Increased cell proliferation in m
mutant hippocampus by NeuN are shown in (h), such as splitting of the sPywithma
in j) and in the DG (arrows in k). sPy, stratum Pyramidale; slm, stratum lacunosu
(magnification 403, 1003).
(F) EEG tracing showing background activity in a representative mutant mouse (
waves (2), and generalized cortical seizure (3). RH and LH: right and left hemisph
(G) Weight gain recovery after rapamycin administration and Kaplan-Meier survi
(H) Chronic rapamycin treatment starting at P8 reduced megalencephaly in P18,
(I) Western blot of vehicle- and rapamycin-treated cortex at P60.
(J) Decreased expression of GFAP in P18 mutant cortex after rapamycin treatmen
44.0 ± 1.9 in mutant, and 1.0 ± 0.4 in rapamycin-treated mutants (p < 0.0001, W
(K) Absence of cortical and hippocampal cytoarchitectural alterations and presen
CX, cortex; DG, dentate gyrus.
Error bars, SEM. See also Figure S1 and Movie S1.
Celimmunoreactive (IR) cells in mutant mice carrying the Rosa-
YFP allele (Figure S1I).
Targeted Inactivation of Tsc1 in the Dorsal
Telencephalic Neuroepithelium Results in Postnatal
Megalencephaly, Cortical Alterations, and Epilepsy
Hyperphosphorylation of pS6S235/6, a downstream effector of
mTORC1, was observed in P15 mutant cortex in most NeuN-IR
neuronal cells, whereas it was not detectable inCre-recombined
GFAP-IR astrocytes (Figure 1A and Figure S1). P15 mutant
cortex demonstrated complete loss of Tsc1 (Figure 1B), concur-
rent reduction in Tsc2, and a marked increase in pS6. Of note,
pAKTSer473 was strongly reduced in mutant cortex while pERK
was increased, in agreement with ERK hyperactivation in TSC-
associated lesions (Jozwiak et al., 2008). No difference in
Raptor, Rictor, or pmTORSer2448/Ser2481 was detected (Fig-
ure 1C). Cortex from heterozygous mice showed the same pat-
tern of mTOR pathway activation as that of controls (Figure 1B).
As in other conditional Tsc1/Tsc2 mouse models, mutant
brains showed megalencephaly (Figure S1E) and increased
cortical thickness (Figure 1A). In line with Emx1-directed Cre
recombination occurring predominantly in glutamatergic neu-
rons, pS6/NeuN-IR enlarged dysplastic neurons were identified
in the Smi311-IR pyramidal cell layer and in an ectopic layer
between layer VI and the corpus callosum (Figures 1A and 1D).
Pyramidal neurons showed abnormal projections and disar-
ranged neurites and axons. Abnormal invaginations of layer I
and circularly shaped clusters of NeuN-IR neurons were
retrieved in outermost and deep cortical layers, respectively (Fig-
ure 1D), together with enhanced activation of GFAP-positive
reactive glia and microglia, and reduced myelination (Figure 1J
and Figure S1N).
Both Cornu Ammonis (CA) 1 and 3 regions and the dentate
gyrus (DG) of the mutant hippocampus were expanded and
disorganized (Figure 1E). Neurons in the granule cell layer of the
DG and in the hilus/CA1/3 regions showed weak and strong
pS6 activation, respectively. Several ring heterotopias were
present throughout the stratum oriens (so), the stratum lacuno-
sum molecolare (slm), and the hippocampal fissure. A higher
frequency of Ki67-IR cells was also observed in the mutant DG.
Notably, hippocampal laminationwas defective inmutant brains,
as indicated by aberrant splitting of the stratumPyramidale (sPy).
pS6-positive neurons were also detected in the arcuate
(ARC) and in the ventromedial hypothalamic (VMH) nuclei ofs of DG in the mutant hippocampus. Inset (c) in (b) shows a ring heterotopia in
utant hippocampus by Ki67 is shown in (m). Severe lamination defects in the
ny ectopic neurons in the so (arrows in h) and several heterotopias in so (arrows
m molecolare; so, stratum orens; DG, dentate gyrus; CA3, cornu ammonis 3
1a), density spectral array (1b), background activity with superimposed sharp
eres.
val curve for vehicle- and rapamycin-treated mice (n = 11).
P40, and P60 mutant mice.
t (P8–P18). GFAP-IR cells counted in the same area field were 4.2 ± 0.8 in WT,
T versus mutant; p < 0.0001, mutant versus rapamycin-treated mutants).
ce of pS6 reactivation (green) in mutant brains after rapamycin discontinuation.
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Figure 2. Deletion of Tsc1 Deregulates Proliferation of Embryonic Cortical Progenitors and Cortical Cytoarchitecture
(A) Quantification of cortical thickness, cell size, cell density, and absolute cell number in P15 mutant and control cortex. Cell size is measured by unbiased
automated cell area calculation. Cell density ismeasured by counting the number of nuclei in the same cortical field of controls andmutants. Absolute cell number
is measured by counting NeuN-IR neurons in the same columnar fields in both control and mutant cortex. Developmental time course analyses of cortical
thickness at E14.5, E16.5, P0, and P7 are shown. n.s., not significant.
(B) Megalencephaly in mutant mice at E16.5 (H&E, 2003).
(C) mTOR pathway activation in control and mutant cortex by western blot as indicated by densitometric analysis.
(D) Activation of mTORC1 (pS6) and proliferation analysis (Ki67) in VZ/SVZ progenitors. Most Ki67-IR cells are pS6-IR cells (6003). BrdU labeling experiment
shows the frequency of cells exiting the cell cycle (BrdU+Ki67/BrdU+) (2003, 1003).
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mTOR Tunes NSC Self-Renewal, DifferentiationP15 mutant mice (Figure S1J), while Cre-recombined GFP-IR
cells were localized in a different hypothalamic region, the
anterior hypothalamic nucleus (AHP), indicating that mTORC1
activation in the ARC and VMH was non-cell-autonomous.
Because mTORC1 activation in the ARC leads to decreased
food intake, poor weight gain in Tsc1c/Emx1-Cre+ mice
could be ascribed to overactive mTORC1 signaling in the
hypothalamus.
Spontaneous epileptic-like seizures were observed in 100%of
our mutants at P13. Video EEG monitoring starting at P12 (n = 6;
Movie S1 available online) showed that background activity in
both control and mutant mice was composed of phases of
1–4 Hz or 6–9 Hz (Figures S1K and S1F). Inmutants, a large spike
frequently appeared just before or at the beginning of ictal
activity, which was associated with generalized spike/waves,
ending with a marked reduction of EEG amplitude and loss of
EEG signal in case of death. Seizure length varied from 30 s to
6 min.
To assess whether mTOR pharmacological inhibition might
revert the cachectic, epileptic, and megalencephalic manifesta-
tions of the mutant phenotype, we delivered rapamycin from P8
to P60. All mutant mice treated by this regimen increased in
weight, stopped developing seizures, and were still alive at
P60 (Figure 1G). Notably, the cortical thickness of rapamycin-
treated mutant mice at P18, P40, and P60, and pS6/Akt phos-
phorylation at P60, were identical to that of vehicle-treated WT
mice (Figures 1H and 1I). Because active cortical neurogenesis
is not detected after P7, rapamycin-induced cortical thickness
normalization might occur through other mechanisms, such as
cortical remodeling. Indeed, rapamycin treatment from P8 to
P18 induced a severe reduction in GFAP-IR reactive astrocytes
(Figure 1J) and rescued the hypomyelination in mutants (Fig-
ure S1N). Within 6–10 days after rapamycin discontinuation, all
mutant mice developed seizures. Although pS6 hyperactivation
was still retrieved inmutants, neither did the cortical size increase
back to the original mutant size, nor did the hippocampus display
alterations (Figure 1K). Thus, epilepsy recurrenceafter rapamycin
suspension might depend on perturbations of synaptic signaling
in postnatal mutant neurons rather than on major cytoarchitec-
tural abnormalities.
Deletion of Tsc1Deregulates Proliferation of Embryonic
Cortical Progenitors and Interferes with Cortical
Development
Increased cell soma size was observed only in the ectopic cell
layer above the corpus callosum (layer VI) in the mutant cortex
(Figure 2A), thus making it unlikely that the enlarged size of
a few cells might be responsible for megalencephaly. Likewise,
no difference in neuropil size and cell density could be detected.
Thus, the increment in cortical thickness in mutants might be
caused by excessive production of cortical cells, likely taking
place during embryonic development, as shown by significantly(E) Pax6-IR RGCs and Tbr2-IR IPCs in mutant VZ and SVZ. Quantification of the n
(F) IZ and CP thickness is higher in mutant cortex as shown by Tuj1 and Tbr1 sta
(G) Reduced expression of Cux1 and Ctip2 in mutant cortex. Tbr1-IR layer disor
(H) Tbr1-IR postmitotic neurons in layer VI at P0 and P15. Tbr2-IR cells in dorsal
Error bars, SEM.
Celincreased NeuN-IR cells in the same columnar cortical field in
mutants.
At E14.5 no differences in brain size and cortical thickness
were observed, while at E16.5 both parameters were increased
in mutants (n = 8, Figures 2A and 2B), which showed complete
loss of Tsc1 protein, reduced level of Tsc2, increased pS6, and
reduced pAktSer473/Thr308 (Figure 2C). No differences were
observed in ERK activation, mTORS2448/S2481 phosphorylation,
or Rictor/Raptor expression.
In E16.5 mutant cortex, intense pS6 staining was detected (1)
in the majority of progenitors located in the VZ/SVZ (Figure 2D),
(2) in scattered neurons throughout the intermediate zone (IZ), (3)
in the subplate (SP), (4) in cells located in the upper layers of the
cortical plate (CP), and (5) in Cajal-Retzius cells in the marginal
zone (MZ) (Figure S1L). A higher frequency of Ki67-IR cells was
detected in VZ/SVZ, with most proliferating cells being also
pS6-IR (Figure 2D). To understand whether the enhanced prolif-
eration of mutant VZ/SVZ progenitors was associated with
a decrease in the cell fraction that exited the cell cycle, we per-
formed labeling with bromodeoxyuridine (BrdU) at E15.5 (Fig-
ure 2D). After 24 hr, the frequency of cells exiting the cell cycle
(BrdU+ Ki67) was significantly lower in mutant VZ/SVZ than in
controls, with a 20% increase in BrdU-IR cells. Interestingly,
the number of Pax6-IR VZ radial glial cells (RGCs), SVZ Tbr2-
IR intermediate progenitor cells (IPCs), and PH3-IR IPCs under-
going mitosis was increased in mutant cortex, suggesting that
their symmetry of division was abnormal (Figure 2E). In agree-
ment with the pS6 pattern, mutant CP and IZ were thicker (Fig-
ure 2F). Expression of Cux1, a marker of both VZ/SVZ and upper
layers II–IV, was almost absent in mutant VZ/SVZ progenitors
(Figure 2G). Similarly, expression of CTIP2, a marker of deep
layer V, was restricted to scattered prospective mutant pyra-
midal neurons, suggesting premature progenitor differentiation.
Tbr1-IR neurons in the SP were highly disorganized.
When the laminar structure of the cortex was analyzed
perinatally, a significant expansion of Tbr1-IR neurons in layer
VI was observed, suggestive of premature differentiation (Fig-
ure 2H). However, postnatally, Tbr1 expression was downregu-
lated in aberrant layer VI cells, because these neurons might
not mature properly (Figures 1A and 1C). Increased numbers of
Tbr2-IR cells in the mutant dorsal SVZ were also detected at
both P0 and P15.
Activation of the mTOR Pathway in eNSCs Finely
Regulates Their Self-Renewal Ability
To assess the role of mTOR in NSCs ex vivo, we isolated naive
cortical eNSCs by NeuroSphere Assay (NSA) at E16.5, i.e.,
when cortical thickness in mutants started to be significantly
higher. Inhibition of mTOR by chronic rapamycin administration
resulted in a remarkable reduction in NSC long-term self-renewal
(Figure 3A), as mTOR inhibition interfered with growth-factor-
mediated proliferative stimuli.umber of basal IPCs undergoing mitosis (PH3 staining) is shown (2003, 1003).
ining, respectively (1003).
ganization in mutants is evident (2003, 6003).
SVZ at P0 and P15 (2003) are shown.
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Figure 3. Activation of the mTOR Pathway in eNSCs Finely Regulates Their Self-Renewal Ability
(A) Long-term growth curve of E16.5 normal eNSCs chronically treated with vehicle (DMSO) or rapamycin (100 nM).
(B) PCR analysis of gDNA from single-embryo-derived control and mutant eNSCs, showing full recombination of the floxable allele.
(C) FACS analysis of control and mutant eNSCs, before and after 48 hr of rapamycin exposure. FSC, forward scatter.
(D) Phase contrast microphotographs of control and mutant eNSCs (4003).
(E) GFAP-IR and nestin-IR cells in undifferentiated mutant eNSCs (3003, inset 5003). Western blot for GFAP in control and mutant lines is shown.
(F) Higher pS6 phosphorylation in mutant eNSCs (3003).
Cell Stem Cell
mTOR Tunes NSC Self-Renewal, Differentiation
452 Cell Stem Cell 9, 447–462, November 4, 2011 ª2011 Elsevier Inc.
Cell Stem Cell
mTOR Tunes NSC Self-Renewal, DifferentiationNext, we established fully recombined E16.5 eNSC lines from
single-embryo-derived mutant cortex (eight NSC lines per geno-
type) (Figure 3B). Mutant eNSCs showed increased cell size,
which was reverted by rapamycin (p < 0.005, n = 3) (Figure 3C).
Enlarged cell size was not detected in freshly isolated mutant
E16.5 cortical cells, likely due to the very low frequency of
NSCs in the E16.5 cortex in vivo (not shown). Even in the pres-
ence of EGF and FGF2, mutant eNSC cultures appeared differ-
entiated and, in fact, comprised many abnormally enlarged
GFAP-IR astrocyte-like cells (Figures 3D and 3E). Tuj1-IR
neuronal cells were never retrieved in either control or mutant
eNSCs. All mutant eNSCs were pS6-IR (Figure 3F).
Interestingly, strong activation of the proglial Signal Trans-
ducer and Activator of Transcription 3 (STAT3) pathway was
observed upon mTOR hyperactivation, as shown by higher
pSTAT3Ser727 in mutant than in WT or heterozygous eNSCs (Fig-
ure 3G). Accordingly, nuclear translocation of mTOR-dependent
pSTAT3Ser727 and mTOR-independent pSTAT3Tyr705 was
detected only in mutant eNSCs (46.1% ± 2.5% pSTAT3Ser705
and 47.4% ± 4.9% pSTAT3Tyr705 -IR cells). In line with the role
of STAT3 signaling in promoting GFAP expression by binding
to its promoter, GFAP-IR cells in undifferentiated mutant
cultures were also pSTAT3Ser727/Tyr705 IR. To mimic the preco-
cious differentiation of mutant eNSCs by ligand-mediated
STAT3 activation, we exposed naive eNSCs to leukemia
inhibitory factor (LIF) (Figure 3H). LIF addition promoted
pSTAT3Ser727/Tyr705 nuclear translocation and highly increased
the fraction of pS6-IR eNSCs, indicating that STAT3 activation
was mediated by enhanced mTOR activity. Most significantly,
LIF-induced STAT3 activation resulted in the premature differen-
tiation of eNSCs into neuronal and astroglial cells, which were
pSTAT3 IR. Interestingly, 48 hr exposure of mutant eNSCs to ra-
pamycin was sufficient to revert the activation of mTORC1 (Fig-
ure 3I), pSTAT3Ser727 (not shown), and the number of GFAP-IR
cells to WT levels (Figure S3).
To test whether abnormal eNSC differentiation could also be
retrieved upon mTORC1 hyperactivation induced through other
mechanisms, we transduced E16.5 naive eNSCs with lentiviral
vectors coding for GFP (mock) or the gain-of-function mutant
form of Rheb (RhebQ64L), which constitutively activates
mTORC1 in a GTP-dependent manner, with no involvement of(G) STAT3 signaling activation upon mTOR hyperactivation, as shown by higher p
analysis of pSTAT3Ser727 normalized over the relative total STAT3 protein expressi
localization of pSTAT3Ser727 in GFAP-IR cells in undifferentiated mutant eNSCs i
(H) Activation of STAT3-dependent signaling by LIF treatment results in the prema
Tuj1-IR cell hyperphosphorylating pS6).
(I) Exposure to rapamycin reduces the frequency of pS6-IR and GFAP-IR cells in
(J) Validation of RhebQ64L transduction in eNSCs by western blot for FLAG in
eNSCs. mTORC1 pathway activation in RhebQ64L-transduced eNSCs, as show
strated. No difference in the activation of mTORC2was observed, as indicated by
on control and RhebQ64L-transduced eNSC lines, the latter comprising many a
(K) Long-term growth curve (P5–P15) and clonal efficiency of control and Tsc1 m
(L) mTOR pathway activation in control and Tsc1 mutant eNSCs as indicated by
(M) Mutant and control eNSCs were treated with 100 nM rapamycin for the ind
pS6S235/6. Changes in PKCa, Akt, and pS6 phosphorylation were expressed as r
(N) Quantitative and semiquantitative RT-PCR indicating increased expression o
(O) Heatmap showing the 140 differentially expressed genes (DEGs) identified b
(P) Semiquantitative RT-PCR validation of some DEGs.
(Q) GPNMB expression in human SEGA.
Error bars, SEM. See also Figure S2, Table S1, Supplemental Lists 1A and 1B, T
CelmTORC2. RhebQ64L eNSCs showed high pS6 and low pAktS473
(Figure 3J) and pAktT308 (not shown), likely through the activation
of an mTORC1-dependent negative feedback loop, rather than
by loss of mTORC2 activity, because phosphorylation status of
the mTORC2 downstream target PKCa did not change (Fig-
ure 3J). Most RhebQ64L eNSCs were pS6 IR, did comprise
a high frequency of GFAP-IR cells, and, accordingly, hyperphos-
phorylated pSTAT3S727, all features that were restored to control
levels by rapamycin (not shown).
Long-term self-renewal and clonal efficiency were decreased
in mutant eNSCs at early passages (P2–P25), resulting in the
extinction ofmostmutant eNSC lines (Figure 3K). However, three
out of eight mutant NSC lines self-renewed efficiently for more
than 25 subculturing passages, suggesting the selection of cells
escapingmTOR dependence for growth, because no changes in
mTOR activation were detected in low- and high-passage
mutant eNSCs (Figure S2). Interestingly, inhibition of mTOR
activity by chronic rapamycin in mutant eNSCs under prolifera-
tive conditions was ineffective in rescuing their reduced long-
term self-renewing ability. Remarkably, although heterozygous
mice did not manifest any phenotype in vivo, heterozygous
eNSC lines were endowed with higher self-renewal than WT
and mutant eNSCs (Figure 3K).
Each eNSC line was different in terms of mTOR activation
(western blot, Table S1). Tsc1 and Tsc2 were strongly reduced,
and pS6 was highly increased in all mutant cultures, with pAkt
decreased in most mutant lines. pERK, mTOR, pmTORS2481/
2448, Raptor, Rictor (Figure 3L), and pPKCaSer657 (expression at
time zero, Figure 3M) did not change. To discriminate the relative
contribution of mTORC1 and mTORC2 in Akt signaling, we took
advantage of both short and long treatments with rapamycin,
which inhibit mTORC1 and mTORC2, respectively. One-hour
and eight-hour exposures of mutant eNSCs to rapamycin
strongly enhanced Akt phosphorylation on both T308 and
S473, indicating the release of the mTORC1-dependent feed-
back (Figure 3M). Because pPKCaSer657 did not change upon
prolonged rapamycin exposure, mTORC2 was unlikely to be
involved in decreased AktS473 phosphorylation (Figure 3M).
Given that heterozygous eNSCs did not activate the mTOR
pathway in vitro (Figure 3L), their enhanced self-renewal might
relate to mTOR-independent, Tsc1/Tsc2-dependent pathways,STAT3S727 level in mutant than in WT and heterozygous eNSCs. Densitometric
on (four eNSC lines per group) is shown. Immunofluorescence showing nuclear
s also shown.
ture generation of Tuj1-IR and GFAP-IR cells and in mTORC1 activation (inset,
mutant cultures.
untransduced (naive), mock-transduced (GFP), and RhebQ64L-transduced
n by reduced pAktS473, and increased pS6S235/6 and pSTAT3S727, is demon-
unchanged phosphorylation in pPKCaS657. Immunocytochemistry for pS6S235/6
berrant GFAP-IR cells, is also shown.
utant eNSCs.
densitometric analysis.
icated time and analyzed by western blot for pPKCaS657, pAKTS473/T308, and
elative levels over untreated cells at time point 0.
f c-myc and its transcriptional target Emp1 in heterozygous eNSCs.
y global gene expression profiling of control and mutant eNSCs.
able S2, and Figure S3.
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Figure 4. Activation of the mTOR Pathway in eNSCs Ex Vivo Controls their Neuronal Differentiation and Maturation
(A) Experimental paradigm for multilineage differentiation of NSCs.
(B) Tuj1-, nestin-, and GFAP-IR cells in FGF2-stimulated progenitor cultures. The majority of mutant cells were pS6 positive (3003). Inset: mutant cell coex-
pressing Tuj1 and pS6.
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mTOR Tunes NSC Self-Renewal, Differentiationactivated by mitogens. Because Tsc2 represses the cell cycle
regulator c-myc (Schmidt et al., 2009), reduction in Tsc2 by
Tsc1 haploinsufficiency (Figure 3L and Table S1) resulted in
c-myc overexpression (Figure 3N). Remarkably, expression of
Emp1/Tmp1, a direct transcriptional target of c-myc and a posi-
tive regulator of cell proliferation, was also strikingly enhanced in
heterozygous eNSCs (Figure 3N), suggesting that c-myc protein
was functionally active. In agreement with the lack of phenotype
in heterozygous mice in vivo, c-myc expression was similar in
E16.5 WT, heterozygous, and mutant cortex, from which eNSC
lines were originally established, and, overall, significantly lower
than in eNSCs (Figure 3N). Because c-myc is also directly regu-
lated by Akt, reduced pAkt in mutant eNSCs might lead to
a significant decrease in c-myc expression in mutant eNSCs
(Figure 3N) and to reduced growth in vitro. Thus, mTOR-inde-
pendent and mTOR-dependent regulation of c-myc expression
may account for the differences in self-renewal detected in
heterozygous and mutant eNSCs in vitro, respectively.
WT and mutant eNSCs were also subjected to transcriptome-
wide gene expression profiling, with more than 140 differentially
expressed genes found (Figure 3O and List S1), some of which
were also validated by RT-PCR (Figure 3P). Some top-ranking
genes upregulated in mutant eNSCs (i.e., Gpnmb, SerpinA3,
S100, GFAP, and c-met) were also highly expressed in TSC
patient lesions, such as Gpnmb in SEGAs (Figure 3Q). Thus,
ex vivo expanded mutant eNSCs faithfully reproduce molecular
traits typical of TSC neurological lesions.
Activation of themTOR Pathway in eNSCs Controls their
Neuronal Differentiation and Maturation
WT and mutant eNSCs were induced to differentiate by with-
drawal of growth factors, and to mature by the addition of fetal
bovine serum (FBS), for up to a total 10 days in vitro (DIV) (Fig-
ure 4A). After culturing for 3 DIV in the presence of the sole
FGF2 (a condition that drives the commitment of eNSCs into
bipotent/unipotent progenitors), control eNSCs differentiated
into nestin-IR progenitors, showing negligible expression of
lineage-specific markers, while mutant eNSCs gave rise to a
high frequency of pS6/Tuj1- and pS6/GFAP-IR cells, with
remarkable decrease in nestin expression (Figure 4B and Table
S2). Exposure of mutant progenitors to rapamycin greatly
reduced the number of Tuj1-IR, partially that of GFAP-IR cells,
and inhibited mTORC1 activation (Figure 4C).
Under maturation-promoting culture conditions, although ex-
hibiting a normal frequency of astrocytes and oligodendrocytes
(Figures 4D and 4E and Table S2), mutant cultures were almost
completely devoid of neurons, as assessed by both early (Tuj1,
Figure 4D) and late (MAP2, not shown) neuronal markers.(C) pS6, Tuj1, and GFAP expression in mutant progenitors after 72 hr exposure t
(D) Tuj1-IR neurons and GFAP-IR astrocytes derived from control and mutant pro
(3003, 6003) is shown. Most cells in differentiated mutant cultures activate mTO
(E) GalC-IR oligodendrocytes derived from control and mutant progenitors after
(F) Increased frequency of apoptotic cells in FGF2-stimulated mutant Tuj1-IR pro
(G) Differentiating (3 days FGF2) RhebQ64L-transduced eNSCs gave rise to Tuj1
FBS) RhebQ64L-transduced eNSCs contained aberrant Tuj1-IR cells. Tuj1-IR c
arrow) were FLAG negative, i.e., derived from untransduced cells. Only Tuj1/FLA
(H) Increased differentiation of naive eNSCs exposed to LIF in the presence of F
Error bars, SEM. See also Table S2 and Figure S3.
CelThus, continuous mTOR activation in mutant FGF2-stimulated
neuroblasts in culture and lack of proper non-cell-autonomous
proneuronal survival signals in the in vitro milieu inhibited their
terminal maturation, leading to their apoptotic death (Figure 4F).
Of note, mTOR hyperactivation in astroglial cells was not detri-
mental to their maturation and survival (Figure 4D and Table
S2). Premature eNSC differentiation and consequent neuronal
loss upon maturation were detected also in RhebQ64L eNSCs
(Figure 4G). Again, LIF-mediated, mTOR-dependent STAT3 acti-
vation in FGF2-stimulated naive cultures resulted in early
neuronal and astroglial differentiation (Figure 4H). To be noted,
when added to maturing cells, rapamycin was ineffective in
rescuing neuronal loss, suggesting the involvement of Tsc1/
Tsc2-dependent, mTORC1-independent functions or rapamy-
cin-insensitive mTORC1-dependent mechanisms in the control
of late neuronal differentiation processes.
Remarkably, mTOR inhibition by chronic exposure of naive
eNSC to rapamycin during differentiation resulted in the com-
plete abrogation of neuronal production (Figure S3).
Loss of Tsc1Expression during Embryonic Development
Severely Impairs the Organization of the Postnatal
SVZ Niche
Postnatal hydrocephalus was likely caused by ependyma
defects (Figure 5A). In Rosa-YFP mutant mice, putative radial
glia and S100b-IR ependymal cells, at E16.5 and P15, respec-
tively, were both GFP and pS6 IR and localized in the dorsal/
medial walls of the ventricles, being absent from the lateral
wall (Figure S1M and Figure 5A). As detected by electron micro-
scopy (EM), mutant ependymal cells of the dorsal wall were
larger in size and highly undifferentiated, containing large nuclei
with lax chromatin, nomature nucleoli, many smoothERcisterns,
and few mitochondria. Although showing deuterosomes and
basal bodies, they harbored immature and disorganized cilia.
Thus, dorsally located mutant ependymal cells displayed typical
features of pre-ependymal cells, suggesting that their untimely
differentiation led to hydrocephalus.
Most interestingly, an aberrantly expanded SVZ region was
detected in P15 mutant brains, which was reminiscent of TSC
SENs, which are static, benign lesions characterized by low
proliferation, scant pS6 activation, and a mixed glio-neuronal
phenotype (Figures 5A and 5B). Accordingly, there were less
Ki67-IR cells in the putative SEN-like region than were in
controls, with no difference in the frequency of apoptotic cells
(not shown). Mutant dorsal SVZ expansion contained some
pS6-IR cells (Figure 5B and Table S3); many cells expressing
doublecortin (DCX), Tuj1, and PSA-NCAM (Figure 5B and not
shown), also organized as small heterotopic clusters; ando rapamycin (3003).
genitors after FBS addition (2003). pS6 immunoreactivity in differentiated lines
RC1, as shown by pS6 activation (magnification 3003).
FBS addition (2003).
genitor cells, as detected by cleaved-caspase 3 (Casp3).
-IR cells that were pS6S235/6 and FLAG positive (inserts). Differentiated (5 days
ells showing a normal morphology in RhebQ64L-transduced cultures (white
G-IR cells were counted in mutant eNSCs.
GF2 for 3 days.
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cells were also retrieved at the peripheral-most edges (Fig-
ure 5C). Notably, DCX-IR progenitors were found at increased
numbers and in ectopic locations also in the mutant SGZ of
the DG (Figure 5D). Mutant SVZ showed significant reduction
in both Tsc1 and Tsc2 proteins, with no activation in pS6 or
difference in pERK or pAkt (Figure 5E).
Whereas accumulation of Type A neuroblasts could be
detected dorsally, alterations in Type B SC distribution were
observed along the entire wall of the SVZ (Figure 5F). Indeed,
TypeB and TypeB1 cells, i.e., the subset contacting the ventricle
with the primary cilium,were large, withmany nuclearmembrane
fusions, and accumulated in the dorsal and lateral SVZ as cell
clusters. Type C transit progenitors were not affected. Aberrant
niche organization could be detected also in ventral regions,
where SVZ was not observed. Given that progenitors in the
dorsal SVZ should normally migrate from dorsolateral to ventral
striatal SVZ (Kakita and Goldman, 1999), mTOR hyperactivation
in early postnatal SVZ progenitors might have impaired their
migration ventrally, eventually contributing to the development
of the aberrant dorsal mass.
To assess whether altered proliferation of mutant embryonic
SCs might be responsible for the aberrant expansion of post-
natal SVZ progenitors, a ‘‘birth-dating’’ experiment was adapted
to comply with the early lethality of mutant mice. BrdU was given
at E15.5 and litters were sacrificed at P18. A 20% increase in the
percentage of BrdU-retaining cells could be detected in P18
mutant dorsolateral SVZ, with some BrdU-retaining cells being
also pS6 IR (n = 3) (Figure 5G).
A massive enlargement of the dorsal SVZ was observed
protruding into the ventricle as early as at P0 all throughout
P18 (Figure 6 and Table S3) and was GFP-positive, and thus
Cre-recombined (Figure 6A). This ectopic cell mass invaded
the prospective corpus callosum (CC) region, forcing amyelinic
axons, which in controls clearly delimited the SVZ, to project
far away from the ventricular surface (Figure 6B).
The frequency of Ki67 cells in mutant VZ/SVZ was higher at
embryonic and early postnatal stages (E16.5 and P0) than late
postnatally (P7 and P15), indicating a progressive decline in
the proliferative ability of mutant SVZ progenitors (Figure 2D, Fig-
ure 5B, Figure 6C, and Table S3). To confirm these findings, mice
were given pulses of BrdU every 12 hr from P5 to P7. P7 mutant
SVZ contained a lower fraction of BrdU-IR cells than that of
controls (33.9% ± 1.5% and 14.8% ± 1.2% in WT and mutant
SVZ, respectively; p < 0.01), confirming reduced proliferation
capacity of postnatal mutant SVZ progenitors, as in SENs.Figure 5. Loss of Tsc1 Expression during Embryonic Development Sev
(A) Enhanced dilatation of ventricles in mutant brains at P15 (H&E). Recombinati
Tsc1c//Emx1-Cre+/RosaR-YFPmice is shown. S100b expression in control andm
ependyma. N, nucleus.
(B) DAPI counterstaining showing increased number of cells in dorsolateral co
progenitor marker doublecortin (DCX) expression in the dorsal SVZ is shown. Arr
dorsal SVZ (1003, 2003) is evident.
(C) Tbr2-IR cells are retrieved at the edge of the massive expansion (2003).
(D) Increased numbers of DCX-IR neuronal progenitors in the mutant SGZ of the
(E) mTOR activation analysis performed by western blot on P15 SVZ tissues (n =
(F) Enlarged and immature Type B cells in the lateral and ventral wall of the muta
(G) BrdU-IR cell quantification in the dorsolateral SVZ at P18, after BrdU pulse a
Error bars, SEM. See also Table S3 and Figure S4.
CelAlso, pS6 remained consistently higher in mutants at P0, while
decreasing at P7 and P15 (Figure 6D and Table S3).
Both hydrocephalus and abnormal expansion of dorsal SVZ
were reverted in rapamycin-treated mutant mice, but did not
reoccur upon rapamycin suspension, in spite of pS6 reactivation
(Figure 6E). Interestingly, Gpnmb, previously found to be
overexpressed in mutant eNSCs and human SEGAs (Figures
3O and 3P), was detected also in aberrant mutant SVZ expan-
sion (Figure 6F), reinforcing the hypothesis that this region
truly recapitulated human SEN. Remarkably, pSTAT3 activation
was also observed in mutant cortex, SVZ, and hippocampus
(Figure 6G).
To assess if postnatal mutant SVZ NSCs were also character-
ized by premature differentiation, we established NSC lines at P7
and P18. None of the mutant SVZ NSC lines showed Cre-medi-
ated Tsc1 loss, suggesting that Cre-recombined dorsal SVZ
NSCs, characterized by low proliferation rate in vivo (Figure 5B
and Figure 6C), were likely taken over in vitro by fast-proliferating
NSCs from nonrecombined SVZ regions, which could not be
excluded from the dissected tissue. To overcome this limitation,
we enforced the expression of RhebQ64L in naive P15 SVZ
NSCs (Figure S4), which, as E16.5 NSCs, displayed premature
differentiation into neuronal and glial cells and impaired terminal
neuronal maturation.
Loss of Tsc1Expression during Embryonic Development
Led to Defects in Neuronal Migration along the Rostral
Migratory Stream
The mutant rostral migratory stream (RMS) contained a high
frequency of pS6-IR cells, few peripherally localized KI67-IR
cells, and multiple layers of DCX-IR cells (Figure 7). Interestingly,
remnants of the olfactory ventricle, which should have disap-
peared by P3, were still detected in the center of the mutant
RMS. Uniciliated and multiciliated cells, located around the
olfactory ventricle at P7 and P15, respectively, displayed fea-
tures typical of immature radial glia cells, such as disorganized
microtubules and abundant smooth ER. Nuclear distribution
profiles at P15 indicated that mutant RMS cells dispersed
throughout the parenchyma, while in controls, they were orga-
nized in compact clusters (Figure 7B). EM analysis showed
that mutant RMS neuroblasts at P7 were very tightly associated
and did not migrate properly, while at P15 they displayed few
union complexes, thusmigratingmostly as single cells or in small
cell clusters.
In agreement with the impaired migration ability of mutant
RMS neuroblasts, the anatomical targets of RMS migration,erely Impairs the Organization of the Postnatal SVZ Niche
on of Tsc1 allele in the dorsal and medial walls by GFP expression and pS6 in
utant ventricles (1003, 2003) is also shown, as is EM of dorsal wall and dorsal
rner of SVZ. SVZ proliferation (Ki67), mTORC1 activation (pS6), and Type A
ow indicates a DCX-IR heterotopia. High frequency of GFAP-IR cells in mutant
DG at P15 (magnification 2003). DG, dentate gyrus; SGZ, subgranular zone.
3). (*), aspecific band for TSC1.
nt ventricle (by EM).
t E15.5. BrdU/pS6-IR cells in the mutant SVZ are indicated by an arrow.
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Figure 6. Late Postnatal Mutant SVZ Progenitors Were Endowed with Reduced Proliferation Ability
(A) Recombination of Tsc1 allele by GFP staining in the mutant aberrant expansion at P7 (1003). LV, lateral ventricle.
(B) EM analysis of the tumor-like lesion in mutant SVZ at P7.
(C) Proliferation rate in the aberrant expansion by Ki67 staining at P0 and P7 (1003).
(D) Higher pS6 in mutant P0 and P7 SVZ (1003).
(E) Chronic rapamycin treatment reduced both hydrocephalus and dorsal SVZ mass (P60), which did not reoccur after rapamycin suspension, in spite of pS6
reactivation (Rapa OFF; pS6-IR cells, arrow).
(F) Gpnmb expression in the SVZ expansion of P15 mutant mice.
(G) pSTAT3 activation in P15 mutant cortex, SVZ, and hippocampus (arrow, pSTAT3-IR cells).
Error bars, SEM. See also Table S3.
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shown by H&E and by Tbr2 and calretinin staining, the mitral
and the glomerular cell layers were disorganized, with the
granule cell layer being highly expanded. In line with the above
findings, treatment of mutant mice with rapamycin also reverted
the RMS phenotype (Figure 7D).
Taken together, these results suggest that SVZ Type A Tsc1-
deficient neuroblasts, which were produced in excess by Type
B cells, did not mature properly and were not capable of
sustaining proper chain migration (Figure 7E).
DISCUSSION
mTOR Activation in Embryonic Progenitors Deregulates
Self-Renewal andDifferentiation, Leading to Alterations
in Embryonic and Postnatal NSC Compartments In Vivo
Maintenance of different somatic tissues is dependent on the
presence of a resident SC pool with self-renewal potential that
generates differentiating progeny. The balance between self-
renewal and differentiation needs to be finely tuned to ensure
proper tissue homeostasis. Accumulating evidence suggests
that persistent mTORC1 activation in SC compartments leads
to increased SC proliferation followed by SC exhaustion (Gan
et al., 2008; Sun et al., 2010; Castilho et al., 2009). Accordingly,
Tsc1 deletion in Emx1-expressing neuroepithelial cells resulted
in the transient expansion of both VZ and SVZ progenitors
during mid-late cortical neurogenesis due to alterations in the
symmetry of differentiative/neurogenic divisions. This cell ampli-
fication contributed to the expansion of most cortical layers
and to megalencephaly, and was followed by a progressively
reduced mitotic activity of NSCs postnatally. Of note, the func-
tional terminal maturation of the excessively generated mutant
neuronal cells was defective, as indicated by the presence of
aberrant SMI311-IR neurons, by downregulation of markers of
mature neurons, and by development of seizures. At the same
time, the deregulated proliferation of embryonic VZ/SVZ NSC
compartment was responsible for the deranged homeostasis
of the postnatal SVZ niche, which resulted in the formation of
ectopic periventricular masses, mostly composed of neuro-
blasts. Again, correct maturation and specialization of postnatal
RMS neuroblasts was negatively affected by Tsc1 loss, because
the OBs were severely reduced in size and highly disorganized.
Notably, the developmental defects observed in our mutant
mice were different from those described in most mouse models
of TSC. Only recently, Tsc2 loss in radial glial cells at E13.5 by
hGFAP-Cre recombination resulted in the generation of a mouse
model that more closely mimicked TSC-associated alterations
(Way et al., 2009). Whereas this study reported that the increase
in cortical thickness arose postnatally, we detected it at E16.5, in
line with the embryonic origin of cortical alterations in TSC
patients (Holmes and Stafstrom, 2007). The difference in timing
and onset of alterations in cortical thickness implies the involve-
ment of different neural cell lineages: during embryogenesis,
hyperactivation of mTOR increased the generation of cells
belonging to the neuronal lineage, whereas persistent activation
of the pathway postnatally contributed to cortical remodeling,
likely by promoting an increase in reactive astrocytes.
Likewise, whereas reduced expression of the postmitotic
neuronal marker Tbr1 in layer VI cells in P15 mutants was ex-Celplained by Way et al. (2009) as the result of lower numbers of
neurons generated during embryogenesis, we demonstrated
that this was due to defects in terminal neuronal maturation.
Remarkably, while taking into account that the in vitro milieu
does not fully reproduce the variety of signals retrieved in vivo,
some in vivo features of Tsc1c/c/Emx1-Cre+ mice, such as the
progressively reduced NSC proliferation, their premature neu-
ronal differentiation, and impaired maturation, were also ob-
served in E16.5 mutant eNSCs when expanded ex vivo as
neurospheres.
mTORC1 Activation Controls Self-Renewal
and Neuronal Differentiation in eNSCs In Vitro
by Modulating Akt and STAT3 Pathways
Our in vitro observations are in partial agreement with findings
in Tsc2 null neuroepithelial progenitors (NEPs) at E10.5 (Onda
et al., 2002). In fact, ectopic expression of GFAP and increased
cell size were detected also in NEPs. However, while enhanced
proliferation was observed in Tsc2 mutant NEPs, Tsc1 mutant
eNSCs undergo a dramatic reduction in self-renewal ability,
likely due to the attenuation of the PI3K-Akt pathway, which
was not reported in E10.5 NEPs. Indeed, reduced Akt phosphor-
ylation in mutant eNSCs was mainly due to the activation of a
regulatory mTORC1-dependent negative feedback loop, which
was relieved by short rapamycin treatment. Accordingly, we
did not find evidence of mTORC2 involvement.
Increasing Akt phosphorylation, by enforced Akt-1 expres-
sion, ROS stimulation, Nf1 production, or Pten deletion (Sinor
and Lillien, 2004; Le Belle et al., 2011; Dasgupta and Gutmann,
2005; Gregorian et al., 2009), results in enhanced NSC prolifera-
tion and self-renewal, although this effect might be cell and
stage specific (Bonaguidi et al., 2011). Correspondingly,
reduced Akt activity by mTORC1-dependent regulatory feed-
back in mutant NSCs negatively controls their self-renewal
ability in vivo and in vitro. Interestingly, Akt hypophosphorylation
might counteract the activation of proproliferative mediators,
such as c-myc (Gregory et al., 2003), which we showed to
be hyperfunctional upon Tsc1 haploinsufficiency in vitro. As
opposed to neurofibromatosis (NF), in which haploinsufficiency
induces phenotypic abnormalities in patients and animal models
(Dasgupta andGutmann, 2005), the eNSC Tsc1 haploinsufficient
phenotype in vitro doesn’t have an in vivo correlate. This is in
agreement with the requirement for somatic second hit TSC1
or TSC2 mutations for tuber formation in TSC patients (Crino
et al., 2010).
We identified the transcription factor STAT3 as a central player
in inducing premature neuronal and astroglial differentiation in
Tsc1 mutant eNSCs. STAT3 phosphorylation on Ser727, which
allows transcriptional activation, is directly regulated by mTOR
(Yokogami et al., 2000). Accordingly, pSTAT3Ser727 is activated
in about 50% of mutant eNSCs under proliferative conditions,
and STAT3 activation by ligand stimulation results in the same
precocious generation of differentiated progeny. Overall, STAT3
activation might be the link between mTOR hyperactivation and
premature eNSC differentiation. Indeed, STAT3 is also highly
phosphorylated in the cortex, the SVZ, and the hippocampus
of our mutant mice in vivo, as well as in patients’ CTs and SEGAs
(Baybis et al., 2004; Chan et al., 2004). Accordingly, STAT3 tran-
scriptional target genes, such as GFAP and SerpinA3, are foundl Stem Cell 9, 447–462, November 4, 2011 ª2011 Elsevier Inc. 459
Figure 7. Loss of Tsc1 Expression during Embryonic Development Led to Defects in Neuronal Migration along the RMS
(A) DAPI staining and pS6 in control andmutant rostral migratory stream (RMS) at P15. Ki67 proliferating cells can be seen at the borders of the mutant RMS. DCX
staining in RMS (coronal and sagittal sections, 1003 and 403, respectively) is shown, as is mutant RMS containing remnants of the ventricle at P15 (by EM).
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lesions (Ess et al., 2004).
In the end, self-renewal, proliferation, and differentiation of
NSCs are finely orchestrated by different intracellular pathways
(i.e. PI3K/Akt and STAT3), which depend directly on mTOR, con-
firming its pivotal role in controlling NSC biology.
EXPERIMENTAL PROCEDURES
Generation of Tsc1 Floxed/Emx1-Cre Mice
To generate Tsc1c/Emx1-Cre and Tsc1c/cEmx1-Cre animals, mixed back-
ground (129S4/SvJae, C57BL/6) Tsc1c/ mice or Tsc1c/c mice (Jackson)
were intercrossed with Emx1-Cre heterozygous mice. We used (c), (WT),
and () to denote the conditional (floxed), WT, and null alleles of Tsc1, respec-
tively; the formal name of the c allele is Tsc1tm1Djk. Tsc1mutants were geno-
typed by tail-derived gDNA PCR by using primers described previously
(Uhlmann et al., 2002b). All animal experiments were approved by and per-
formed in accordance with the guidelines of the International Animal Care
and Use Committee.
Immunostaining on Paraffin-Embedded and Frozen Sections
Brains from embryos or from intracardially perfused postnatal mice were fixed
for 24 hr in 4% PFA. Sixteen-micron frozen sections were directly incubated
with primary Abs. From paraffin-embedded brains, 5 mm paraffin sections
were obtained, deparaffinized, rehydrated, treated for antigen retrieval, and
incubated in 10%serumblocking solution prior to incubationwith primary anti-
bodies. See Supplemental Experimental Procedures for the list of primary
antibodies.
Cell Cycle Exit and BrdU Birth-Dating Experiments
For cell cycle exit, timed, pregnant mice were injected with BrdU (Sigma) intra-
peritoneally at 40 mg/g body weight at E15.5 and sacrificed at E16.5. For BrdU
birth-dating, timed, pregnant mice were injected with BrdU at E15.5 and sacri-
ficed at P18. For BrdU staining, sections were treated with 2NHCl for 20min at
RT followed by two washes with 0.1 M boric acid (pH 8.5) for 10 min at RT prior
to blocking. The primary antibody used was rat anti-BrdU (Serotec).
Immunoblotting
Cortical tissues from embryos and cortical/SVZ tissues from postnatal mice
were dissected out and directly stored at 80C. Each frozen tissue was
homogenized in 103 volume of RIPA lysis buffer (10 mM Tris-Cl [pH 7.2],
150 mM NaCl, 1 mM EDTA [pH 8]) with 1% Triton X-100, 1% deoxycholate,
0.1% SDS, and protease and phosphatase inhibitor mixture (Roche). Samples
were prepared according to standard western blotting protocol. See Supple-
mental Experimental Procedures for details.
Isolation and Characterization of NSCs from WT and Mutant Mice
NSC cultures were established under mild hypoxic (5% O2) culture conditions
from the E16.5 cortex of WT and mutant mice. For population analysis, cells
were plated at 83 103 cells/cm2, and the formed spheres were collected every
3–5 days. For clonogenic assays, cells derived from the dissociation of clonal
single neurospheres were seeded in 96-well plates, and the number of
secondary spheres generated was assessed after 8–10 days.
Differentiation of NSC Cultures
To evaluate multipotency, NSCs were treated as in Parras et al. (2004). For the
experiment with LIF (Peprotech), naive eNSCs were plated in standard media
with or without 10 ng/ml LIF.(B) Diagrams showing the RMS cellular organization by toluidine-blue-stained se
(red arrow, intercellular spaces; [*]: migrating neuroblasts) is shown.
(C) H&E, Tbr2, and calretinin staining of OBs showing disorganization of mitral an
layer; GCL, granule cell layer.
(D) pS6 and Ki67 staining after chronic rapamycin treatment (403).
(E) Model summarizing cell lineage defects in the mutant SVZ.
Error bars, SEM.
CelLentiviral Vector Generation and Cell Infection
RhebQ64L construct (kindly provided by Drs. Jiang and Vogt; The Scripps
Research Institute, La Jolla, CA, USA) was cloned into amonocistronic transfer
lentiviral vector pCCL.sin.cPPT.PGK.GFP.WPRE11, after removal of the GFP
cassette. eNSCs were transduced with 1 3 107 TU/ml of lentiviral vectors
for 16 hr. Infection efficiency was assessed by counting the frequency of
FLAG-IR cells and by western blotting for FLAG.
Treatment with Rapamycin
For in vivo administration, rapamycin (LC-Labs, USA) was dissolved in 100%
ethanol, stored at 20C, and diluted in a vehicle solution containing 5%
Tween 80 and 5% PEG 400 (Sigma, St. Louis, MO) immediately before injec-
tion. Mice were intraperitoneally injected with 6 mg/kg of drug or vehicle every
2 days. For in vitro treatment, rapamycin was dissolved in DMSO and used at
a final concentration of 100 nM in medium.
Molecular Analysis
Total RNA from eNSCs lines was extracted using the RNeasy Mini Kits
(QIAGEN). cDNA was obtained by using Omniscript RT Kit (QIAGEN). All
cDNAs were normalized to the b-actin RT-PCR product. For microarray anal-
ysis, refer to Supplemental Experimental Procedures.
Statistical Analysis
Results for continuous variables were expressed as mean ± standard error of
the mean (SEM). Two-group comparisons were performed with the indepen-
dent samples’ Student t test. p < 0.05 was considered statistically significant.
*p < 0.05; **p < 0.01; ***p < 0.005; ****p < 0.001.
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lists, and Supplemental Experimental Procedures and can be found with this
article online at doi:10.1016/j.stem.2011.09.008.
ACKNOWLEDGMENTS
This work was supported by Associazione Sclerosi Tuberosa (AST) to R.G. We
thank Paolo Caferra for help and assistance with molecular analysis and Luca
Muzio for critical reading of the manuscript.
Received: January 16, 2011
Revised: June 20, 2011
Accepted: September 15, 2011
Published: November 3, 2011
REFERENCES
Baybis, M., Yu, J., Lee, A., Golden, J.A., Weiner, H., McKhann, G., 2nd,
Aronica, E., and Crino, P.B. (2004). mTOR cascade activation distinguishes
tubers from focal cortical dysplasia. Ann. Neurol. 56, 478–487.
Bonaguidi, M.A., Wheeler, M.A., Shapiro, J.S., Stadel, R.P., Sun, G.J., Ming,
G.L., and Song, H. (2011). In vivo clonal analysis reveals self-renewing and
multipotent adult neural stem cell characteristics. Cell 145, 1142–1155.
Castilho, R.M., Squarize, C.H., Chodosh, L.A., Williams, B.O., and Gutkind,
J.S. (2009). mTOR mediates Wnt-induced epidermal stem cell exhaustion
and aging. Cell Stem Cell 5, 279–289.
Chan, J.A., Zhang, H., Roberts, P.S., Jozwiak, S., Wieslawa, G., Lewin-
Kowalik, J., Kotulska, K., and Kwiatkowski, D.J. (2004). Pathogenesis ofmithin sections at P15. EM analysis of control and mutant RMS at P7 and P15
d glomerular layers (403, 1003, 6003). MCL, mitral cell layer; GL, glomerular
l Stem Cell 9, 447–462, November 4, 2011 ª2011 Elsevier Inc. 461
Cell Stem Cell
mTOR Tunes NSC Self-Renewal, Differentiationtuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation
of TSC1 or TSC2 leads to mTOR activation. J. Neuropathol. Exp. Neurol. 63,
1236–1242.
Crino, P.B., Nathanson, K.L., and Henske, E.P. (2006). The tuberous sclerosis
complex. N. Engl. J. Med. 355, 1345–1356.
Crino, P.B., Aronica, E., Baltuch, G., and Nathanson, K.L. (2010). Biallelic TSC
gene inactivation in tuberous sclerosis complex. Neurology 74, 1716–1723.
Dasgupta, B., and Gutmann, D.H. (2005). Neurofibromin regulates neural stem
cell proliferation, survival, and astroglial differentiation in vitro and in vivo.
J. Neurosci. 25, 5584–5594.
Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D.J.,
Ramesh, V., and Silva, A.J. (2008). Reversal of learning deficits in a Tsc2+/-
mouse model of tuberous sclerosis. Nat. Med. 14, 843–848.
Ess, K.C., Uhlmann, E.J., Li, W., Li, H., Declue, J.E., Crino, P.B., and Gutmann,
D.H. (2004). Expression profiling in tuberous sclerosis complex (TSC)
knockout mouse astrocytes to characterize human TSC brain pathology.
Glia 46, 28–40.
Gan, B., Sahin, E., Jiang, S., Sanchez-Aguilera, A., Scott, K.L., Chin, L.,
Williams, D.A., Kwiatkowski, D.J., and DePinho, R.A. (2008). mTORC1-depen-
dent and -independent regulation of stem cell renewal, differentiation, and
mobilization. Proc. Natl. Acad. Sci. USA 105, 19384–19389.
Gorski, J.A., Talley, T., Qiu, M., Puelles, L., Rubenstein, J.L., and Jones, K.R.
(2002). Cortical excitatory neurons and glia, but not GABAergic neurons, are
produced in the Emx1-expressing lineage. J. Neurosci. 22, 6309–6314.
Gregorian, C., Nakashima, J., Le Belle, J., Ohab, J., Kim, R., Liu, A., Smith,
K.B., Groszer, M., Garcia, A.D., Sofroniew, M.V., et al. (2009). Pten deletion
in adult neural stem/progenitor cells enhances constitutive neurogenesis.
J. Neurosci. 29, 1874–1886.
Gregory, M.A., Qi, Y., and Hann, S.R. (2003). Phosphorylation by glycogen
synthase kinase-3 controls c-myc proteolysis and subnuclear localization.
J. Biol. Chem. 278, 51606–51612.
Hobbs, R.M., Seandel, M., Falciatori, I., Rafii, S., and Pandolfi, P.P. (2010). Plzf
regulates germline progenitor self-renewal by opposing mTORC1. Cell 142,
468–479.
Holmes, G.L., and Stafstrom, C.E.; Tuberous Sclerosis Study Group. (2007).
Tuberous sclerosis complex and epilepsy: recent developments and future
challenges. Epilepsia 48, 617–630.
Jozwiak, J., Jozwiak, S., and Wlodarski, P. (2008). Possible mechanisms of
disease development in tuberous sclerosis. Lancet Oncol. 9, 73–79.
Kakita, A., andGoldman, J.E. (1999). Patterns and dynamics of SVZ cell migra-
tion in the postnatal forebrain: monitoring living progenitors in slice prepara-
tions. Neuron 23, 461–472.
Le Belle, J.E., Orozco, N.M., Paucar, A.A., Saxe, J.P., Mottahedeh, J., Pyle,
A.D., Wu, H., and Kornblum, H.I. (2011). Proliferative neural stem cells have
high endogenous ROS levels that regulate self-renewal and neurogenesis in
a PI3K/Akt-dependant manner. Cell Stem Cell 8, 59–71.462 Cell Stem Cell 9, 447–462, November 4, 2011 ª2011 Elsevier IncMeikle, L., Talos, D.M., Onda, H., Pollizzi, K., Rotenberg, A., Sahin, M., Jensen,
F.E., and Kwiatkowski, D.J. (2007). A mouse model of tuberous sclerosis:
neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myeli-
nation, seizure activity, and limited survival. J. Neurosci. 27, 5546–5558.
Onda, H., Crino, P.B., Zhang, H., Murphey, R.D., Rastelli, L., Gould Rothberg,
B.E., and Kwiatkowski, D.J. (2002). Tsc2 null murine neuroepithelial cells are
amodel for human tuber giant cells, and show activation of anmTOR pathway.
Mol. Cell. Neurosci. 21, 561–574.
Orlova, K.A., Tsai, V., Baybis, M., Heuer, G.G., Sisodiya, S., Thom,M., Strauss,
K., Aronica, E., Storm, P.B., and Crino, P.B. (2010). Early progenitor cell marker
expression distinguishes type II from type I focal cortical dysplasias.
J. Neuropathol. Exp. Neurol. 69, 850–863.
Parras, C.M., Galli, R., Britz, O., Soares, S., Galichet, C., Battiste, J., Johnson,
J.E., Nakafuku, M., Vescovi, A., and Guillemot, F. (2004). Mash1 specifies
neurons and oligodendrocytes in the postnatal brain. EMBO J. 23, 4495–4505.
Ridler, K., Suckling, J., Higgins, N., Bolton, P., and Bullmore, E. (2004).
Standardized whole brain mapping of tubers and subependymal nodules in
tuberous sclerosis complex. J. Child Neurol. 19, 658–665.
Schmidt, E.V., Ravitz, M.J., Chen, L., and Lynch, M. (2009). Growth controls
connect: interactions between c-myc and the tuberous sclerosis complex-
mTOR pathway. Cell Cycle 8, 1344–1351.
Sinor, A.D., and Lillien, L. (2004). Akt-1 expression level regulates CNS precur-
sors. J. Neurosci. 24, 8531–8541.
Sun, P., Quan, Z., Zhang, B., Wu, T., and Xi, R. (2010). TSC1/2 tumour
suppressor complex maintains Drosophila germline stem cells by preventing
differentiation. Development 137, 2461–2469.
Uhlmann, E.J., Apicelli, A.J., Baldwin, R.L., Burke, S.P., Bajenaru, M.L., Onda,
H., Kwiatkowski, D., and Gutmann, D.H. (2002a). Heterozygosity for the
tuberous sclerosis complex (TSC) gene products results in increased astrocyte
numbers and decreased p27-Kip1 expression in TSC2+/- cells. Oncogene 21,
4050–4059.
Uhlmann, E.J., Wong, M., Baldwin, R.L., Bajenaru, M.L., Onda, H.,
Kwiatkowski, D.J., Yamada, K., and Gutmann, D.H. (2002b). Astrocyte-
specific TSC1 conditional knockout mice exhibit abnormal neuronal organiza-
tion and seizures. Ann. Neurol. 52, 285–296.
Way, S.W., McKenna, J., 3rd, Mietzsch, U., Reith, R.M., Wu, H.C., and
Gambello, M.J. (2009). Loss of Tsc2 in radial glia models the brain pathology
of tuberous sclerosis complex in the mouse. Hum. Mol. Genet. 18, 1252–1265.
Yokogami, K., Wakisaka, S., Avruch, J., and Reeves, S.A. (2000). Serine
phosphorylation and maximal activation of STAT3 during CNTF signaling is
mediated by the rapamycin target mTOR. Curr. Biol. 10, 47–50.
Young, K.M., Fogarty, M., Kessaris, N., and Richardson, W.D. (2007).
Subventricular zone stem cells are heterogeneous with respect to their embry-
onic origins and neurogenic fates in the adult olfactory bulb. J. Neurosci. 27,
8286–8296..
